Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Wils

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|May 31, 2020
The neuropeptide substance P regulates aldosterone secretion in human adrenalsJulien Wils, Céline Duparc, Anne-Françoise Cailleux, et al.
Cardiovascular Diabetology|March 20, 2019
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patientsThomas Duflot, Lucile Moreau-Grangé, Clothilde Roche, et al.
JCI Insight|October 5, 2016
PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal diseaseZakariae Bram, Estelle Louiset, Bruno Ragazzon, et al.
Clinical Pharmacology and Therapeutics|November 25, 2024
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of MavacamtenLouis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|May 31, 2020
The neuropeptide substance P regulates aldosterone secretion in human adrenalsJulien Wils, Céline Duparc, Anne-Françoise Cailleux, et al.
Cardiovascular Diabetology|March 20, 2019
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patientsThomas Duflot, Lucile Moreau-Grangé, Clothilde Roche, et al.
JCI Insight|October 5, 2016
PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal diseaseZakariae Bram, Estelle Louiset, Bruno Ragazzon, et al.
Clinical Pharmacology and Therapeutics|November 25, 2024
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of MavacamtenLouis Lebreton, Jean-Christophe Boyer, Claire Lafay-Chebassier, et al.
Pageof 4